Application of 13C CPMAS NMR for Qualitative and Quantitative Characterization of Carvedilol and its Commercial Formulations
- 1 May 2012
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 101 (5) , 1763-1772
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- 1H and 13C NMR characteristics of β‐blockersMagnetic Resonance in Chemistry, 2011
- Isomorphism, Disorder, and Hydration in the Crystal Structures of Racemic and Single-Enantiomer Carvedilol PhosphateCrystal Growth & Design, 2010
- Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution ratesAdvanced Drug Delivery Reviews, 2007
- A second polymorph of carvedilolActa Crystallographica Section E Structure Reports Online, 2007
- Analysis of Conformational Polymorphism in Pharmaceutical Solids Using Solid-State NMR and Electronic Structure CalculationsThe Journal of Physical Chemistry B, 2006
- NMR studies of organic polymorphs & solvatesThe Analyst, 2006
- Quantitation of crystalline and amorphous forms of anhydrous neotame using 13C CPMAS NMR spectroscopyJournal of Pharmaceutical Sciences, 2005
- 1H, 13C, 15N NMR analysis of sildenafil base and citrate (Viagra) in solution, solid state and pharmaceutical dosage formsJournal of Pharmaceutical and Biomedical Analysis, 2005
- Validation of quantitative NMRJournal of Pharmaceutical and Biomedical Analysis, 2005
- Quantification of bambuterol hydrochloride in a formulated product using solid-state NMRJournal of Pharmaceutical and Biomedical Analysis, 2005